1.Reitz C, Trenkwalder C, Kretzschmar K, Roesler A, A VE, Berger K: Relation of cerebral small-vessel disease and brain atrophy to mild Parkinsonism in the elderly. Mov Disord 2006, 21(11):1914–1919.
2.Hatate J, Miwa K, Matsumoto M, Sasaki T, Yagita Y, Sakaguchi M, Kitagawa K, Mochizuki H: Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors. Parkinsonism & Related Disorders 2016, 26:29–34.
3.de Laat KF, van Norden AG, Gons RA, van Uden IW, Zwiers MP, Bloem BR, van Dijk EJ, de Leeuw FE: Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs. Stroke 2012, 43(10):2574–2579.
4.de Laat KF, van Norden AGW, Gons RAR, van Oudheusden LJB, van Uden IWM, Bloem BR, Zwiers MP, de Leeuw F-E: Gait in Elderly With Cerebral Small Vessel Disease. Stroke 2010, 41(8):1652–1658.
5.Pinter D, Ritchie SJ, Doubal F, Gattringer T, Morris Z, Bastin ME, del C. Valdés Hernández M, Royle NA, Corley J, Muñoz Maniega S et al: Impact of small vessel disease in the brain on gait and balance. Scientific Reports 2017, 7(1).
6.Kim YJ, Kwon HK, Lee JM, Cho H, Kim HJ, Park HK, Jung NY, San Lee J, Lee J, Jang YK et al: Gray and white matter changes linking cerebral small vessel disease to gait disturbances. Neurology 2016, 86(13):1199–1207.
7.de Laat KF, van den Berg HAC, van Norden AGW, Gons RAR, Olde Rikkert MGM, de Leeuw F-E: Microbleeds Are Independently Related to Gait Disturbances in Elderly Individuals With Cerebral Small Vessel Disease. Stroke 2011, 42(2):494–497.
8.Bennett DA, Beckett LA, Murray AM, Shannon KM, Goetz CG, Pilgrim DM, Evans DA: Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996, 334(2):71–76.
9.Su N, Zhai F-F, Zhou L-X, Ni J, Yao M, Li M-L, Jin Z-Y, Gong G-L, Zhang S-Y, Cui L-Y et al: Cerebral Small Vessel Disease Burden Is Associated with Motor Performance of Lower and Upper Extremities in Community-Dwelling Populations. Frontiers in Aging Neuroscience 2017, 9.
10.Rosano C, Longstreth WT, Boudreau R, Taylor CA, Du Y, Kuller LH, Newman AB: High Blood Pressure Accelerates Gait Slowing in Well-Functioning Older Adults over 18-Years of Follow-Up. Journal of the American Geriatrics Society 2011, 59(3):390–397.
11.Tanner CM, Gilley DW, Goetz CG: A Brief Screening Questionnaire for Parkinsonism. Annals of Neurology 1990, 28(2):267–268.
12.Höglinger GU, Rissling I, Metz A, Ries V, Heinermann A, Prinz H, Spieker S, Deuschl G, Baum E, Oertel WH: Enhancing recognition of early Parkinsonism in the community. Movement Disorders 2004, 19(5):505–512.
13.Dahodwala N, Siderowf A, Baumgarten M, Abrams A, Karlawish J: Screening questionnaires for parkinsonism: A systematic review. Parkinsonism & Related Disorders 2012, 18(3):216–224.
14.Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR et al: Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. The Lancet Neurology 2013, 12(8):822–838.
15.Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA: MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol 1987, 149(2):351–356.
16.Zhu Y-C, Tzourio C, Soumaré Ac, Mazoyer B, Dufouil C, Chabriat H: Severity of Dilated Virchow-Robin Spaces Is Associated With Age, Blood Pressure, and MRI Markers of Small Vessel Disease. Stroke 2010, 41(11):2483–2490.
17.Rubino FA: Gait disorders. The neurologist 2002, 8(4):254–262.
18.Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Langhorne P et al: Association of gait and balance disorders with age-related white matter changes: The LADIS Study. Neurology 2008, 70(12):935–942.
19.Kreisel SH, Blahak C, Bazner H, Inzitari D, Pantoni L, Poggesi A, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM et al: Deterioration of gait and balance over time: the effects of age-related white matter change—the LADIS study. Cerebrovasc Dis 2013, 35(6):544–553.
20.Pantoni L, Basile AM, Pracucci G, Asplund K, Bogousslavsky J, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M et al: Impact of age-related cerebral white matter changes on the transition to disability—the LADIS study: rationale, design and methodology. Neuroepidemiology 2005, 24(1–2):51–62.
21.van Norden AG, de Laat KF, Gons RA, van Uden IW, van Dijk EJ, van Oudheusden LJ, Esselink RA, Bloem BR, van Engelen BG, Zwarts MJ et al: Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol. BMC Neurol 2011, 11:29.
22.Studenski S: Gait Speed and Survival in Older Adults. Jama 2011, 305(1).
23.van der Holst HM, van Uden IWM, Tuladhar AM, de Laat KF, van Norden AGW, Norris DG, van Dijk EJ, Rutten-Jacobs LC, de Leeuw F-E: Factors Associated With 8-Year Mortality in Older Patients With Cerebral Small Vessel Disease. JAMA Neurology 2016, 73(4).
24.Verghese J, LeValley A, Hall CB, Katz MJ, Ambrose AF, Lipton RB: Epidemiology of Gait Disorders in Community-Residing Older Adults. Journal of the American Geriatrics Society 2006, 54(2):255–261.